Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Dudgeon

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Cheminformatics|April 13, 2022
Galaxy workflows for fragment-based virtual screening: a case study on the SARS-CoV-2 main proteaseSimon Bray, Tim Dudgeon, Rachael Skyner, et al.
Immunology Letters|February 14, 2002
Selective cleavage of human IgG by the matrix metalloproteinases, matrilysin and stromelysinAndrew J H Gearing, Susan J Thorpe, Karen Miller, et al.
Journal of Chemical Information and Modeling|May 25, 2023
Fragment Merging Using a Graph Database Samples Different Catalogue Space than Similarity SearchStephanie Wills, Ruben Sanchez-Garcia, Tim Dudgeon, et al.
Science (New York, N.Y.)|November 9, 2023
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitorsMelissa L Boby, Daren Fearon, Matteo Ferla, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Cheminformatics|April 13, 2022
Galaxy workflows for fragment-based virtual screening: a case study on the SARS-CoV-2 main proteaseSimon Bray, Tim Dudgeon, Rachael Skyner, et al.
Immunology Letters|February 14, 2002
Selective cleavage of human IgG by the matrix metalloproteinases, matrilysin and stromelysinAndrew J H Gearing, Susan J Thorpe, Karen Miller, et al.
Journal of Chemical Information and Modeling|May 25, 2023
Fragment Merging Using a Graph Database Samples Different Catalogue Space than Similarity SearchStephanie Wills, Ruben Sanchez-Garcia, Tim Dudgeon, et al.
Science (New York, N.Y.)|November 9, 2023
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitorsMelissa L Boby, Daren Fearon, Matteo Ferla, et al.
Pageof 1